REGENERON PHARMACEUTICALS, INC. Accumulated OCI 2009-2026 | REGN
What is accumulated oci?
Accumulated other comprehensive income (OCI) includes unrealized gains and losses from foreign currency translation, available-for-sale securities, and pension adjustments.
What is REGENERON PHARMACEUTICALS, INC.'s current accumulated oci?
REGENERON PHARMACEUTICALS, INC. (REGN) annual accumulated oci for 2025 was $77.5M, a 1081.01% increase from 2024. REGENERON PHARMACEUTICALS, INC. accumulated oci for the quarter ending March 31, 2026 was $11.9M.
What was REGENERON PHARMACEUTICALS, INC.'s accumulated oci in 2024?
REGENERON PHARMACEUTICALS, INC. annual accumulated oci for 2024 was $-7.9M, a 90.23% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s accumulated oci in 2023?
REGENERON PHARMACEUTICALS, INC. annual accumulated oci for 2023 was $-80.9M, a 66.12% increase from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year accumulated oci CAGR?
REGENERON PHARMACEUTICALS, INC. accumulated oci grew at a compound annual growth rate (CAGR) of 21.47% from FY2020 to FY2025, going from $29.3M to $77.5M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $77.5M | +1081.0% | 10-K |
| FY2024 | $-7.9M | +90.2% | 10-K |
| FY2023 | $-80.9M | +66.1% | 10-K |
| FY2022 | $-238.8M | -811.5% | 10-K |
| FY2021 | $-26.2M | -189.4% | 10-K |
| FY2020 | $29.3M | +38.9% | 10-K |
| FY2019 | $21.1M | +271.5% | 10-K |
| FY2018 | $-12.3M | -2150.0% | 10-K |
| FY2017 | $600,000 | +104.7% | 10-K |
| FY2016 | $-12.8M | -249.8% | 10-K |
| FY2015 | $8.6M | -83.6% | 10-K |
| FY2014 | $52.3M | +4498.2% | 10-K |
| FY2013 | $-1.2M | -1.9% | 10-K |
| FY2012 | $-1.2M | +37.4% | 10-K |
| FY2011 | $-1.9M | +25.3% | 10-K |
| FY2010 | $-2.5M | -338.6% | 10-K |
| FY2009 | $1.0M | - | 10-K |